These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16724953)

  • 1. Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation.
    Götte M
    Curr Pharm Des; 2006; 12(15):1867-77. PubMed ID: 16724953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pyrophosphate analogue foscarnet traps the pre-translocational state of HIV-1 reverse transcriptase in a Brownian ratchet model of polymerase translocation.
    Marchand B; Tchesnokov EP; Götte M
    J Biol Chem; 2007 Feb; 282(5):3337-46. PubMed ID: 17145704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific footprinting reveals differences in the translocation status of HIV-1 reverse transcriptase. Implications for polymerase translocation and drug resistance.
    Marchand B; Götte M
    J Biol Chem; 2003 Sep; 278(37):35362-72. PubMed ID: 12819205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet.
    Das K; Balzarini J; Miller MT; Maguire AR; DeStefano JJ; Arnold E
    ACS Chem Biol; 2016 Aug; 11(8):2158-64. PubMed ID: 27192549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides.
    Marchand B; Götte M
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1823-35. PubMed ID: 15183347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of HIV-1 reverse transcriptase by 4'-Ethynyl-2-fluoro-2'-deoxyadenosine triphosphate, a translocation-defective reverse transcriptase inhibitor.
    Michailidis E; Marchand B; Kodama EN; Singh K; Matsuoka M; Kirby KA; Ryan EM; Sawani AM; Nagy E; Ashida N; Mitsuya H; Parniak MA; Sarafianos SG
    J Biol Chem; 2009 Dec; 284(51):35681-91. PubMed ID: 19837673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamics of HIV-1 reverse transcriptase in action elucidates the mechanism of action of non-nucleoside inhibitors.
    Bec G; Meyer B; Gerard MA; Steger J; Fauster K; Wolff P; Burnouf D; Micura R; Dumas P; Ennifar E
    J Am Chem Soc; 2013 Jul; 135(26):9743-52. PubMed ID: 23742167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
    Menéndez-Arias L
    Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutations F61A and A62V in the fingers subdomain of HIV-1 reverse transcriptase on the translocational equilibrium.
    Scarth B; McCormick S; Götte M
    J Mol Biol; 2011 Jan; 405(2):349-60. PubMed ID: 21056575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
    Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
    J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nucleotide-dependent degradation of nucleic acids by DNA and RNA polymerases].
    Sosunov VV; Viktorova LS
    Mol Biol (Mosk); 2004; 38(5):804-22. PubMed ID: 15554184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
    Sarafianos SG; Hughes SH; Arnold E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphate.
    Ray AS; Yang Z; Shi J; Hobbs A; Schinazi RF; Chu CK; Anderson KS
    Biochemistry; 2002 Apr; 41(16):5150-62. PubMed ID: 11955063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of primer-induced conformational dynamics of HIV-1 reverse transcriptase on polymerase translocation and inhibition.
    Auger A; Beilhartz GL; Zhu S; Cauchon E; Falgueyret JP; Grobler JA; Ehteshami M; Götte M; Melnyk RA
    J Biol Chem; 2011 Aug; 286(34):29575-83. PubMed ID: 21737446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.
    Xia Q; Radzio J; Anderson KS; Sluis-Cremer N
    Protein Sci; 2007 Aug; 16(8):1728-37. PubMed ID: 17656585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
    Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
    J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
    Patel PH; Jacobo-Molina A; Ding J; Tantillo C; Clark AD; Raag R; Nanni RG; Hughes SH; Arnold E
    Biochemistry; 1995 Apr; 34(16):5351-63. PubMed ID: 7537090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.
    Tchesnokov EP; Obikhod A; Schinazi RF; Götte M
    J Biol Chem; 2008 Dec; 283(49):34218-28. PubMed ID: 18940786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.